The effects of single and repeated phencyclidine administration on [125I] iomazenil binding in the rat brain

Koichi Kaneko, Akeo Kurumaji, Haruo Shibuya, Toshitaka Nabeshima, Michio Toru

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We measured [125I] iomazenil binding, labeling the central-type benzodiazepine receptor in 37 discrete rat brain areas following single (7.5 mg/kg, i.p.) and repeated (7.5 mg/kg/day x 14 days, i.p.) treatment with phencyclidine (PCP), a non-competitive antagonist of the N-methyl-D-aspartate (NMDA)type glutamate receptor, using in vitro quantitative autoradiographic receptor binding assay. Both single and repeated PCP treatment produced heterogeneous changes in the rat brain in a similar manner, the magnitude of change in [125I] iomazenil binding being generally greater in the repeated treatment group than in the single treatment group. A significant increase in [125I] iomazenil binding was observed in the superficial layer (layer I-IV) of the parietal cortex in both of the PCP treatment groups and the CA1 of the hippocampus of the repeated PCP-treated group. There was a significant decrease in [125I] iomazenil binding in the piriform cortex of the repeated PCP-treated group. These results suggest that the blockade of NMDA receptor-mediated glutamatergic neurotransmission by PCP produces the compensational alterations in the central-type benzodiazepine receptor antagonist binding, and that the observed diversity may be due to dissimilar modes of organizations between glutamatergic and the GABA(γ-aminobutyric acid)-benzodiazepine receptor complex.

Original languageEnglish
Pages (from-to)279-287
Number of pages9
JournalNeurochemistry International
Volume29
Issue number3
DOIs
Publication statusPublished - 01-01-1996
Externally publishedYes

Fingerprint

Phencyclidine
GABA-A Receptors
Brain
N-Methyl-D-Aspartate Receptors
Aminobutyrates
Parietal Lobe
Glutamate Receptors
Synaptic Transmission
gamma-Aminobutyric Acid
Hippocampus
iomazenil

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Kaneko, Koichi ; Kurumaji, Akeo ; Shibuya, Haruo ; Nabeshima, Toshitaka ; Toru, Michio. / The effects of single and repeated phencyclidine administration on [125I] iomazenil binding in the rat brain. In: Neurochemistry International. 1996 ; Vol. 29, No. 3. pp. 279-287.
@article{17db460f2f864cf38431d43c2395fe85,
title = "The effects of single and repeated phencyclidine administration on [125I] iomazenil binding in the rat brain",
abstract = "We measured [125I] iomazenil binding, labeling the central-type benzodiazepine receptor in 37 discrete rat brain areas following single (7.5 mg/kg, i.p.) and repeated (7.5 mg/kg/day x 14 days, i.p.) treatment with phencyclidine (PCP), a non-competitive antagonist of the N-methyl-D-aspartate (NMDA)type glutamate receptor, using in vitro quantitative autoradiographic receptor binding assay. Both single and repeated PCP treatment produced heterogeneous changes in the rat brain in a similar manner, the magnitude of change in [125I] iomazenil binding being generally greater in the repeated treatment group than in the single treatment group. A significant increase in [125I] iomazenil binding was observed in the superficial layer (layer I-IV) of the parietal cortex in both of the PCP treatment groups and the CA1 of the hippocampus of the repeated PCP-treated group. There was a significant decrease in [125I] iomazenil binding in the piriform cortex of the repeated PCP-treated group. These results suggest that the blockade of NMDA receptor-mediated glutamatergic neurotransmission by PCP produces the compensational alterations in the central-type benzodiazepine receptor antagonist binding, and that the observed diversity may be due to dissimilar modes of organizations between glutamatergic and the GABA(γ-aminobutyric acid)-benzodiazepine receptor complex.",
author = "Koichi Kaneko and Akeo Kurumaji and Haruo Shibuya and Toshitaka Nabeshima and Michio Toru",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/0197-0186(96)00006-X",
language = "English",
volume = "29",
pages = "279--287",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "3",

}

The effects of single and repeated phencyclidine administration on [125I] iomazenil binding in the rat brain. / Kaneko, Koichi; Kurumaji, Akeo; Shibuya, Haruo; Nabeshima, Toshitaka; Toru, Michio.

In: Neurochemistry International, Vol. 29, No. 3, 01.01.1996, p. 279-287.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effects of single and repeated phencyclidine administration on [125I] iomazenil binding in the rat brain

AU - Kaneko, Koichi

AU - Kurumaji, Akeo

AU - Shibuya, Haruo

AU - Nabeshima, Toshitaka

AU - Toru, Michio

PY - 1996/1/1

Y1 - 1996/1/1

N2 - We measured [125I] iomazenil binding, labeling the central-type benzodiazepine receptor in 37 discrete rat brain areas following single (7.5 mg/kg, i.p.) and repeated (7.5 mg/kg/day x 14 days, i.p.) treatment with phencyclidine (PCP), a non-competitive antagonist of the N-methyl-D-aspartate (NMDA)type glutamate receptor, using in vitro quantitative autoradiographic receptor binding assay. Both single and repeated PCP treatment produced heterogeneous changes in the rat brain in a similar manner, the magnitude of change in [125I] iomazenil binding being generally greater in the repeated treatment group than in the single treatment group. A significant increase in [125I] iomazenil binding was observed in the superficial layer (layer I-IV) of the parietal cortex in both of the PCP treatment groups and the CA1 of the hippocampus of the repeated PCP-treated group. There was a significant decrease in [125I] iomazenil binding in the piriform cortex of the repeated PCP-treated group. These results suggest that the blockade of NMDA receptor-mediated glutamatergic neurotransmission by PCP produces the compensational alterations in the central-type benzodiazepine receptor antagonist binding, and that the observed diversity may be due to dissimilar modes of organizations between glutamatergic and the GABA(γ-aminobutyric acid)-benzodiazepine receptor complex.

AB - We measured [125I] iomazenil binding, labeling the central-type benzodiazepine receptor in 37 discrete rat brain areas following single (7.5 mg/kg, i.p.) and repeated (7.5 mg/kg/day x 14 days, i.p.) treatment with phencyclidine (PCP), a non-competitive antagonist of the N-methyl-D-aspartate (NMDA)type glutamate receptor, using in vitro quantitative autoradiographic receptor binding assay. Both single and repeated PCP treatment produced heterogeneous changes in the rat brain in a similar manner, the magnitude of change in [125I] iomazenil binding being generally greater in the repeated treatment group than in the single treatment group. A significant increase in [125I] iomazenil binding was observed in the superficial layer (layer I-IV) of the parietal cortex in both of the PCP treatment groups and the CA1 of the hippocampus of the repeated PCP-treated group. There was a significant decrease in [125I] iomazenil binding in the piriform cortex of the repeated PCP-treated group. These results suggest that the blockade of NMDA receptor-mediated glutamatergic neurotransmission by PCP produces the compensational alterations in the central-type benzodiazepine receptor antagonist binding, and that the observed diversity may be due to dissimilar modes of organizations between glutamatergic and the GABA(γ-aminobutyric acid)-benzodiazepine receptor complex.

UR - http://www.scopus.com/inward/record.url?scp=0030247152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030247152&partnerID=8YFLogxK

U2 - 10.1016/0197-0186(96)00006-X

DO - 10.1016/0197-0186(96)00006-X

M3 - Article

C2 - 8885287

AN - SCOPUS:0030247152

VL - 29

SP - 279

EP - 287

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 3

ER -